Hydrolytic Reactivity Trends among Potential Prodrugs of the O<sup>2</sup>-Glycosylated Diazeniumdiolate Family. Targeting Nitric Oxide to Macrophages for Antileishmanial ActivityCarlos A. Valdez, Larry K. Keefer, Joseph J. Barchi et al.|Journal of Medicinal Chemistry|2008Cited by 41
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Kim, Javed Khan, Berkley E. Gryder et al.|Nature Communications|2024Cited by 19
Unexpected Incorporation of Bromine at a Non-anomeric Position during the Synthesis of an O<sup>2</sup>-Glycosylated DiazeniumdiolateJoseph E. Saavedra, Larry K. Keefer, Keith M. Davies et al.|Organic Preparations and Procedures International|2009Cited by 3